Published: April 13, 2021
Company has said it is postponing deployment in Europe following concerns about blood clots in US
The European commission has said it is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it is delaying the deployment of its coronavirus vaccine across Europe following concerns in the US about a small number of blood clots.
After US health agencies recommended states temporarily halt use of the shot on Tuesday, Johnson & Johnson said in a statement it had been “reviewing these cases with European health authorities” and had “made the decision to proactively delay the rollout of our vaccine in Europe”.
Continue reading...from The Guardian https://ift.tt/32hQXRr
via
0 Comments